Compounds and methods for the treatment of ocular disorders
US11459351B1 · kind B1 · utility
1Cited by
23References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 5, 2021 |
| Grant date | Oct 4, 2022 |
| Priority date | — |
| Expiry date | Apr 5, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P27/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are compositions and methods for the treatment or prevention of ocular surface disorders including meibomian gland dysfunction, blepharitis, dry eye disease and other inflammatory and/or infectious diseases of the anterior surface of the eye(s). Said compositions and methods comprise keratolytic conjugates which demonstrate keratolytic activity, and anti-inflammatory or other desirable activities. Topical administration of said compositions to the eyelid margin or surrounding areas provides therapeutic benefit to patients suffering from ocular surface disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.